DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,046,000 | +5.5% | 41,320 | 0.0% | 0.28% | +3.7% |
| Q4 2017 | $3,835,000 | +5.4% | 41,320 | -2.5% | 0.27% | -2.9% |
| Q3 2017 | $3,637,000 | -8.1% | 42,396 | -9.6% | 0.28% | -12.0% |
| Q2 2017 | $3,959,000 | -23.8% | 46,916 | -22.8% | 0.32% | -26.1% |
| Q1 2017 | $5,195,000 | +2.0% | 60,743 | -7.2% | 0.43% | -10.1% |
| Q4 2016 | $5,094,000 | -19.1% | 65,443 | -18.5% | 0.48% | -16.3% |
| Q3 2016 | $6,298,000 | -20.2% | 80,343 | +2.8% | 0.57% | -25.1% |
| Q2 2016 | $7,892,000 | -3.3% | 78,143 | -9.2% | 0.76% | -2.2% |
| Q1 2016 | $8,163,000 | +0.9% | 86,049 | -1.3% | 0.78% | -5.0% |
| Q4 2015 | $8,094,000 | -11.6% | 87,149 | -18.9% | 0.82% | -13.6% |
| Q3 2015 | $9,156,000 | -12.2% | 107,449 | -11.8% | 0.95% | -4.8% |
| Q2 2015 | $10,425,000 | -3.8% | 121,799 | -4.6% | 1.00% | +2.8% |
| Q1 2015 | $10,842,000 | -8.7% | 127,699 | -7.8% | 0.97% | -4.9% |
| Q4 2014 | $11,871,000 | +0.6% | 138,499 | -10.9% | 1.02% | +0.4% |
| Q3 2014 | $11,806,000 | -3.8% | 155,387 | -0.3% | 1.02% | -4.5% |
| Q2 2014 | $12,273,000 | +5.5% | 155,887 | +0.5% | 1.06% | -0.5% |
| Q1 2014 | $11,632,000 | -0.5% | 155,087 | +2.4% | 1.07% | -0.6% |
| Q4 2013 | $11,695,000 | +11.2% | 151,487 | -0.1% | 1.07% | -5.0% |
| Q3 2013 | $10,515,000 | +4.7% | 151,687 | -4.4% | 1.13% | +3.5% |
| Q2 2013 | $10,045,000 | – | 158,687 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |